CG Life Acquires Berry & Company Public Relations, Further Expanding Strategic Communications Services for BioPharma and Healthcare
21 Mayo 2024 - 7:30AM
Business Wire
Enhanced capabilities and expertise drive
growth in clinical communications supporting patient advocacy,
clinical research, and drug development
CG Life, a science-first, tech-enabled agency for
life science, has acquired Berry & Company Public
Relations, a New York City-based public relations agency
focused on service to life sciences and medical technology
companies. The acquisition significantly expands the range of CG
Life communications expertise and services to support clients in
the biopharma and medical sectors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240521529009/en/
(Graphic: Business Wire)
Berry & Company is a specialized PR firm with more than 25
years of experience in healthcare communications. The agency
provides a complete range of public relations services to clients,
including traditional and sponsored media, social media strategy
and execution, content development, issues management, and crisis
communications with expertise across a range of therapeutic areas,
including rare diseases, oncology, immunology, neurological
diseases, and orthopedic surgery.
“More than ever, today's marketing and communication agencies
must be closely aligned with both their clients and the rapidly
growing epicenters of innovation in healthcare. With Berry &
Company’s pharma capabilities and New York presence, we are
strategically positioned at the heart of the action in one of the
world’s most robust and dynamic environments for life science
innovation,” said CG Life CEO David Ormesher. “This marks CG
Life’s second acquisition in one month, further emphasizing our
commitment to building a new and powerful force in life sciences
communications."
The acquisition of Berry & Company represents another
milestone in CG Life's growth strategy. In April 2024, the company
announced its acquisition of Toolhouse, a leading digital marketing
agency for biopharma.
“We are continuing to execute our vision to build the premier
science-first, technology-enabled omnichannel healthcare
communications agency. The combined expertise of CG Life,
Toolhouse, and Berry & Company positions us to deliver a more
comprehensive range of services and deep expertise to deliver
positive results for leaders in pharma, life science, and
healthcare technology,” added Ormesher.
Following the acquisition, Berry & Company’s leadership team
has joined CG Life. Bill Berry will serve as Senior Vice
President, Public Relations, Adam Daley as Vice President,
Social Media, and Tim McDonough as Vice President,
Finance.
“We are very pleased to have the opportunity to combine our
experience with the wide range of capabilities available at CG
Life. We share their vision of outstanding service to clients to
drive innovation and meaningful outcomes,” said Berry & Company
Principal and Founder Bill Berry. “We look forward to
unlocking new opportunities together and delivering even greater
value to our clients through a combined critical understanding of
life science and broader integrated healthcare communications.”
About Berry & Company Public Relations
For more than 25 years, Berry & Company has developed and
executed public relations programs that support well-informed
healthcare decisions. Our clients have included both emerging and
established pioneers in healthcare technology and drug development,
and our customized programs have played a central role in
supporting hundreds of landmark advances in medical science
including more than 60 FDA approvals and 300+ preclinical and
clinical research programs. We have also been privileged to work in
close collaboration with hundreds of leaders in clinical care,
pharmaceutical, biotechnology, and medical device research and
patient advocacy. Visit berrypr.com to learn more.
About CG Life
For more than two decades, CG Life has provided integrated
marketing solutions to companies leading the way in therapeutics,
medical devices, diagnostics, and research tools and services.
Committed to the profound impact of science on everyday lives, CG
Life blends scientific understanding, strategic imagination, and
digital innovation to guide clients through the biggest leaps they
make. Visit cglife.com to learn more.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240521529009/en/
Isabella Rodriguez CG Life irodriguez@cglife.com